+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Neurology Clinical Trials Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • October 2026
  • Region: Global
  • Grand View Research
  • ID: 5457652
The global neurology clinical trials market size was valued at USD 10.9 billion in 2025 and is projected to grow from11.5 billion in 2026 to USD 19.2 billion by 2033, at a CAGR of 7.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 46.9% in 2025. The market growth is driven by the increasing prevalence of neurological disorders; the expansion of clinical research pipelines; the growing adoption of advanced biomarkers, artificial intelligence, and digital technologies in neurological clinical trials; and increasing pharmaceutical and biotechnology investments and outsourcing of neurology clinical trials.

Global Neurology Clinical Trials Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global neurology clinical trials market report based on phase, study design, indication, indication by study design, indication by phase, value chain, and region:

Indication by Study Design Outlook (Revenue, USD Million, 2021 - 2033)

  • Alzheimer’s Disease
  • Interventional
  • Observational
  • Expanded Access
  • Depression (MDD)
  • Interventional
  • Observational
  • Expanded Access
  • Parkinson's Disease (PD)
  • Interventional
  • Observational
  • Expanded Access
  • Epilepsy
  • Interventional
  • Observational
  • Expanded Access
  • Stroke
  • Interventional
  • Observational
  • Expanded Access
  • Traumatic Brain Injury (TBI)
  • Interventional
  • Observational
  • Expanded Access
  • Amyotrophic Lateral Sclerosis (ALS)
  • Interventional
  • Observational
  • Expanded Access
  • Huntington's Disease
  • Interventional
  • Observational
  • Expanded Access
  • Muscle Regeneration
  • Interventional
  • Observational
  • Expanded Access
  • Others
  • Interventional
  • Observational
  • Expanded Access

Indication Outlook (Revenue, USD Million, 2021 - 2033)

  • Alzheimer’s Disease
  • Depression (MDD)
  • Parkinson's Disease (PD)
  • Epilepsy
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Huntington's Disease
  • Muscle Regeneration
  • Others

Study Design Outlook (Revenue, USD Million, 2021 - 2033)

  • Interventional
  • Observational
  • Expanded Access

Phase Outlook (Revenue, USD Million, 2021 - 2033)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Indication by Phase Outlook (Revenue, USD Million, 2021 - 2033)

  • Alzheimer’s Disease
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Depression (MDD)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Parkinson's Disease (PD)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Epilepsy
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Stroke
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Traumatic Brain Injury (TBI)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Amyotrophic Lateral Sclerosis (ALS)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Huntington's Disease
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Muscle Regeneration
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Others
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Value Chain Outlook (Revenue, USD Million, 2021 - 2033)

  • In-house
  • Outsourcing

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Oman
  • Qatar

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Phase
1.2.2. Study Design
1.2.3. Indication
1.2.4. Value Chain
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. The internal database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Neurology Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Neurological Disorders and Expansion of Clinical Research Pipelines
3.2.1.2. Growing Adoption of Advanced Biomarkers, Artificial Intelligence, and Digital Technologies in Neurological Clinical Trials
3.2.1.3. Increasing Pharmaceutical and Biotechnology Investments and Outsourcing of Neurology Clinical Trials
3.2.2. Market Restraint Analysis
3.2.2.1. High Clinical Trial Costs and Prolonged Drug Development Timelines
3.2.2.2. Patient Recruitment Challenges and Complex Neurological Clinical Trial Endpoints
3.3. Tariff Impact Analysis
3.4. Technology Landscape
3.5. Pricing Model Analysis
3.6. R&D Spending Analysis (2021-2025)
3.7. Clinical Trial Volume Analysis, 2025
3.8. Value Chain Analysis
3.8.1. Supply Trends
3.8.2. Demand Trends
3.9. Market Analysis Tools
3.9.1. Porter’s Five Forces Analysis
3.9.2. PESTEL Analysis
Chapter 4. Neurology Clinical Trials Market: Phase Estimates & Trend Analysis
4.1. Neurology Clinical Trials Market, Phase: Segment Dashboard
4.2. Neurology Clinical Trials Market, Phase: Movement Analysis, 2025 & 2033
4.3. Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
4.4. Phase I
4.4.1. Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.5. Phase II
4.5.1. Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.6. Phase III
4.6.1. Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.7. Phase IV
4.7.1. Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 5. Neurology Clinical Trials Market: Study Design Estimates & Trend Analysis
5.1. Neurology Clinical Trials Market, Study Design: Segment Dashboard
5.2. Neurology Clinical Trials Market, Study Design: Movement Analysis, 2025 & 2033
5.3. Neurology Clinical Trials Market Estimates & Forecasts, Study Design, 2021 - 2033 (USD Million)
5.4. Interventional
5.4.1. Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.5. Observational
5.5.1. Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.6. Expanded Access
5.6.1. Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 6. Neurology Clinical Trials Market: Indication Estimates & Trend Analysis
6.1. Neurology Clinical Trials Market, Indication: Segment Dashboard
6.2. Neurology Clinical Trials Market, Indication: Movement Analysis, 2025 & 2033
6.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication, 2021 - 2033 (USD Million)
6.4. Alzheimer’s Disease
6.4.1. Alzheimer’s Disease Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.5. Depression (MDD)
6.5.1. Depression (MDD) Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.6. Parkinson's Disease (PD)
6.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.7. Epilepsy
6.7.1. Epilepsy Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.8. Stroke
6.8.1. Stroke Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.9. Traumatic Brain Injury (TBI)
6.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.10. Amyotrophic Lateral Sclerosis (ALS)
6.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.11. Huntington's Disease
6.11.1. Huntington's Disease Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.12. Muscle Regeneration
6.12.1. Muscle Regeneration Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.13. Others
6.13.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 7. Neurology Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis
7.1. Neurology Clinical Trials Market, Indication by Study Design: Segment Dashboard
7.2. Neurology Clinical Trials Market, Indication by Study Design: Movement Analysis, 2025 & 2033
7.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
7.4. Alzheimer’s Disease
7.4.1. Alzheimer’s Disease Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.4.2. Alzheimer’s Disease Interventional
7.4.2.1. Alzheimer’s Disease Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.4.3. Alzheimer’s Disease Observational
7.4.3.1. Alzheimer’s Disease Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.4.4. Alzheimer’s Disease Expanded Access
7.4.4.1. Alzheimer’s Disease Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.5. Depression (MDD)
7.5.1. Depression (MDD) Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.5.2. Depression (MDD) Interventional
7.5.2.1. Depression (MDD) Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.5.3. Depression (MDD) Observational
7.5.3.1. Depression (MDD) Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.5.4. Depression (MDD) Expanded Access
7.5.4.1. Depression (MDD) Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.6. Parkinson's Disease (PD)
7.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.6.2. Parkinson’s Disease (PD) Interventional
7.6.2.1. Parkinson’s Disease (PD) Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.6.3. Parkinson’s Disease (PD) Observational
7.6.3.1. Parkinson’s Disease (PD) Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.6.4. Parkinson’s Disease (PD) Expanded Access
7.6.4.1. Parkinson’s Disease (PD) Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.7. Epilepsy
7.7.1. Epilepsy Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.7.2. Epilepsy Interventional
7.7.2.1. Epilepsy Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.7.3. Epilepsy Observational
7.7.3.1. Epilepsy Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.7.4. Epilepsy Expanded Access
7.7.4.1. Epilepsy Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.8. Stroke
7.8.1. Stroke Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.8.2. Stroke Interventional
7.8.2.1. Stroke Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.8.3. Stroke Observational
7.8.3.1. Stroke Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.8.4. Stroke Expanded Access
7.8.4.1. Stroke Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.9. Traumatic Brain Injury (TBI)
7.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.9.2. Traumatic Brain Injury (TBI) Interventional
7.9.2.1. Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.9.3. Traumatic Brain Injury (TBI) Observational
7.9.3.1. Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.9.4. Traumatic Brain Injury (TBI) Expanded Access
7.9.4.1. Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.10. Amyotrophic Lateral Sclerosis (ALS)
7.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.10.2. Amyotrophic Lateral Sclerosis (ALS) Interventional
7.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.10.3. Amyotrophic Lateral Sclerosis (ALS) Observational
7.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.10.4. Amyotrophic Lateral Sclerosis (ALS) Expanded Access
7.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.11. Huntington's Disease
7.11.1. Huntington's Disease Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.11.2. Huntington’s Disease Interventional
7.11.2.1. Huntington’s Disease Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.11.3. Huntington’s Disease Observational
7.11.3.1. Huntington’s Disease Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.11.4. Huntington’s Disease Expanded Access
7.11.4.1. Huntington’s Disease Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.12. Muscle Regeneration
7.12.1. Muscle Regeneration Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.12.2. Muscle Regeneration Interventional
7.12.2.1. Muscle Regeneration Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.12.3. Muscle Regeneration Observational
7.12.3.1. Muscle Regeneration Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.12.4. Muscle Regeneration Expanded Access
7.12.4.1. Muscle Regeneration Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.13. Others
7.13.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.13.2. Others Interventional
7.13.2.1. Others Interventional Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.13.3. Others Observational
7.13.3.1. Others Observational Market Estimates and Forecasts 2021 to 2033 (USD Million)
7.13.4. Others Expanded Access
7.13.4.1. Others Expanded Access Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 8. Neurology Clinical Trials Market: End Use Estimates & Trend Analysis
8.1. Neurology Clinical Trials Market, End Use: Segment Dashboard
8.2. Neurology Clinical Trials Market, End Use: Movement Analysis, 2025 & 2033
8.3. Neurology Clinical Trials Market Estimates & Forecasts, End Use, 2021 - 2033 (USD Million)
8.4. Large Pharmaceutical Companies
8.4.1. Large Pharmaceutical Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
8.5. Small & Mid-sized Pharmaceutical Companies
8.5.1. Small & Mid-sized Pharmaceutical Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
8.6. Others
8.6.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 9. Neurology Clinical Trials Market: Indication by Phase Estimates & Trend Analysis
9.1. Neurology Clinical Trials Market, Indication by Phase: Segment Dashboard
9.2. Neurology Clinical Trials Market, Indication by Phase: Movement Analysis, 2025 & 2033
9.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
9.4. Alzheimer’s Disease
9.4.1. Alzheimer’s Disease Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.4.2. Alzheimer’s Disease Phase I
9.4.2.1. Alzheimer’s Disease Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.4.3. Alzheimer’s Disease Phase II
9.4.3.1. Alzheimer’s Disease Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.4.4. Alzheimer’s Disease Phase III
9.4.4.1. Alzheimer’s Disease Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.4.5. Alzheimer’s Disease Phase IV
9.4.5.1. Alzheimer’s Disease Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.4.6. Depression (MDD) Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.5. Parkinson's Disease (PD)
9.5.1. Parkinson's Disease (PD) Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.5.2. Alzheimer’s Disease Phase I
9.5.2.1. Alzheimer’s Disease Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.5.3. Alzheimer’s Disease Phase II
9.5.3.1. Alzheimer’s Disease Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.5.4. Alzheimer’s Disease Phase III
9.5.4.1. Alzheimer’s Disease Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.5.5. Alzheimer’s Disease Phase IV
9.5.5.1. Alzheimer’s Disease Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.6. Epilepsy
9.6.1. Epilepsy Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.6.2. Epilepsy Phase I
9.6.2.1. Epilepsy Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.6.3. Epilepsy Phase II
9.6.3.1. Epilepsy Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.6.4. Epilepsy Phase III
9.6.4.1. Epilepsy Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.6.5. Epilepsy Phase IV
9.6.5.1. Epilepsy Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.7. Stroke
9.7.1. Stroke Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.7.2. Stroke Phase I
9.7.2.1. Stroke Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.7.3. Stroke Phase II
9.7.3.1. Stroke Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.7.4. Stroke Phase III
9.7.4.1. Stroke Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.7.5. Stroke Phase IV
9.7.5.1. Stroke Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.8. Traumatic Brain Injury (TBI)
9.8.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.8.2. Traumatic Brain Injury (TBI) Phase I
9.8.2.1. Traumatic Brain Injury (TBI) Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.8.3. Traumatic Brain Injury (TBI) Phase II
9.8.3.1. Traumatic Brain Injury (TBI) Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.8.4. Traumatic Brain Injury (TBI) Phase III
9.8.4.1. Traumatic Brain Injury (TBI) Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.8.5. Traumatic Brain Injury (TBI) Phase IV
9.8.5.1. Traumatic Brain Injury (TBI) Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.9. Amyotrophic Lateral Sclerosis (ALS)
9.9.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.9.2. Amyotrophic Lateral Sclerosis (ALS) Phase I
9.9.2.1. Amyotrophic Lateral Sclerosis (ALS) Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.9.3. Amyotrophic Lateral Sclerosis (ALS) Phase II
9.9.3.1. Amyotrophic Lateral Sclerosis (ALS) Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.9.4. Amyotrophic Lateral Sclerosis (ALS) Phase III
9.9.4.1. Amyotrophic Lateral Sclerosis (ALS) Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.9.5. Amyotrophic Lateral Sclerosis (ALS) Phase IV
9.9.5.1. Amyotrophic Lateral Sclerosis (ALS) Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.10. Huntington's Disease
9.10.1. Huntington's Disease Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.10.2. Huntington’s Disease Phase I
9.10.2.1. Huntington’s Disease Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.10.3. Huntington’s Disease Phase II
9.10.3.1. Huntington’s Disease Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.10.4. Huntington’s Disease Phase III
9.10.4.1. Huntington’s Disease Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.10.5. Huntington’s Disease Phase IV
9.10.5.1. Huntington’s Disease Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.11. Muscle Regeneration
9.11.1. Muscle Regeneration Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.11.2. Muscle Regeneration Phase I
9.11.2.1. Muscle Regeneration Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.11.3. Muscle Regeneration Phase II
9.11.3.1. Muscle Regeneration Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.11.4. Muscle Regeneration Phase III
9.11.4.1. Muscle Regeneration Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.11.5. Muscle Regeneration Phase IV
9.11.5.1. Muscle Regeneration Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.12. Others
9.12.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.12.2. Others Phase I
9.12.2.1. Others Phase I Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.12.3. Others Phase II
9.12.3.1. Others Phase II Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.12.4. Others Phase III
9.12.4.1. Others Phase III Market Estimates and Forecasts 2021 to 2033 (USD Million)
9.12.5. Others Phase IV
9.12.5.1. Others Phase IV Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 10. Neurology Clinical Trials Market: Indication by Value Chain Estimates & Trend Analysis
10.1. Neurology Clinical Trials Market, Indication by Value Chain: Segment Dashboard
10.2. Neurology Clinical Trials Market, Indication by Value Chain: Movement Analysis, 2025 & 2033
10.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Value Chain, 2021 - 2033 (USD Million)
10.4. In-house
10.4.1. In-house Market Estimates and Forecasts 2021 to 2033 (USD Million)
10.5. Outsourcing
10.5.1. Outsourcing Market Estimates and Forecasts 2021 to 2033 (USD Million)
Chapter 11. Neurology Clinical Trials Market: Regional Estimates & Trend Analysis
11.1. Regional Market Dashboard
11.2. Regional Market Share Analysis, 2025 & 2033
11.3. North America
11.3.1. North America Market Estimates and Forecasts, 2021-2033 (USD Million)
11.3.2. U.S
11.3.2.1. Key Country Dynamics
11.3.2.2. Competitive Scenario
11.3.2.3. Regulatory Framework
11.3.2.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Million)
11.3.3. Canada
11.3.3.1. Key Country Dynamics
11.3.3.2. Competitive Scenario
11.3.3.3. Regulatory Framework
11.3.3.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Million)
11.3.4. Mexico
11.3.4.1. Key Country Dynamics
11.3.4.2. Competitive Scenario
11.3.4.3. Regulatory Framework
11.3.4.4. Mexico Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4. Europe
11.4.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.2. UK
11.4.2.1. Key Country Dynamics
11.4.2.2. Competitive Scenario
11.4.2.3. Regulatory Framework
11.4.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.3. Germany
11.4.3.1. Key Country Dynamics
11.4.3.2. Competitive Scenario
11.4.3.3. Regulatory Framework
11.4.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.4. France
11.4.4.1. Key Country Dynamics
11.4.4.2. Competitive Scenario
11.4.4.3. Regulatory Framework
11.4.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.5. Italy
11.4.5.1. Key Country Dynamics
11.4.5.2. Competitive Scenario
11.4.5.3. Regulatory Framework
11.4.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.6. Spain
11.4.6.1. Key Country Dynamics
11.4.6.2. Competitive Scenario
11.4.6.3. Regulatory Framework
11.4.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.7. Denmark
11.4.7.1. Key Country Dynamics
11.4.7.2. Competitive Scenario
11.4.7.3. Regulatory Framework
11.4.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.8. Sweden
11.4.8.1. Key Country Dynamics
11.4.8.2. Competitive Scenario
11.4.8.3. Regulatory Framework
11.4.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Million)
11.4.9. Norway
11.4.9.1. Key Country Dynamics
11.4.9.2. Competitive Scenario
11.4.9.3. Regulatory Framework
11.4.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5. Asia Pacific
11.5.1. Asia Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5.2. Japan
11.5.2.1. Key Country Dynamics
11.5.2.2. Competitive Scenario
11.5.2.3. Regulatory Framework
11.5.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5.3. China
11.5.3.1. Key Country Dynamics
11.5.3.2. Competitive Scenario
11.5.3.3. Regulatory Framework
11.5.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5.4. India
11.5.4.1. Key Country Dynamics
11.5.4.2. Competitive Scenario
11.5.4.3. Regulatory Framework
11.5.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5.5. Thailand
11.5.5.1. Key Country Dynamics
11.5.5.2. Competitive Scenario
11.5.5.3. Regulatory Framework
11.5.5.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5.6. South Korea
11.5.6.1. Key Country Dynamics
11.5.6.2. Competitive Scenario
11.5.6.3. Regulatory Framework
11.5.6.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Million)
11.5.7. Australia
11.5.7.1. Key Country Dynamics
11.5.7.2. Competitive Scenario
11.5.7.3. Regulatory Framework
11.5.7.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Million)
11.6. Latin America
11.6.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)
11.6.2. Brazil
11.6.2.1. Key Country Dynamics
11.6.2.2. Competitive Scenario
11.6.2.3. Regulatory Framework
11.6.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Million)
11.6.3. Argentina
11.6.3.1. Key Country Dynamics
11.6.3.2. Competitive Scenario
11.6.3.3. Regulatory Framework
11.6.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7. MEA
11.7.1. MEA Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7.2. South Africa
11.7.2.1. Key Country Dynamics
11.7.2.2. Competitive Scenario
11.7.2.3. Regulatory Framework
11.7.2.4. South Africa Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7.3. Saudi Arabia
11.7.3.1. Key Country Dynamics
11.7.3.2. Competitive Scenario
11.7.3.3. Regulatory Framework
11.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7.4. UAE
11.7.4.1. Key Country Dynamics
11.7.4.2. Competitive Scenario
11.7.4.3. Regulatory Framework
11.7.4.4. UAE Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7.5. Kuwait
11.7.5.1. Key Country Dynamics
11.7.5.2. Competitive Scenario
11.7.5.3. Regulatory Framework
11.7.5.4. Kuwait Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7.6. Oman
11.7.6.1. Key Country Dynamics
11.7.6.2. Competitive Scenario
11.7.6.3. Regulatory Framework
11.7.6.4. Oman Market Estimates and Forecasts, 2021-2033 (USD Million)
11.7.7. Qatar
11.7.7.1. Key Country Dynamics
11.7.7.2. Competitive Scenario
11.7.7.3. Regulatory Framework
11.7.7.4. Qatar Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 12. Competitive Landscape
12.1. Key Participant Categorization
12.1.1. Market Leaders
12.1.2. Emerging Players
12.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
12.3. Company Profiles
12.3.1. Syneos Health
12.3.1.1. Company Overview
12.3.1.2. Financial Performance
12.3.1.3. Product Pipeline Benchmarking
12.3.1.4. Strategic Initiatives
12.3.2. Icon Plc
12.3.2.1. Company Overview
12.3.2.2. Financial Performance
12.3.2.3. Product Pipeline Benchmarking
12.3.2.4. Strategic Initiatives
12.3.3. Lindus Health
12.3.3.1. Company Overview
12.3.3.2. Financial Performance
12.3.3.3. Product Pipeline Benchmarking
12.3.3.4. Strategic Initiatives
12.3.4. AbbVie
12.3.4.1. Company Overview
12.3.4.2. Financial Performance
12.3.4.3. Product Pipeline Benchmarking
12.3.4.4. Strategic Initiatives
12.3.5. GlaxoSmithKline
12.3.5.1. Company Overview
12.3.5.2. Financial Performance
12.3.5.3. Product Pipeline Benchmarking
12.3.5.4. Strategic Initiatives
12.3.6. Aurora Healthcare
12.3.6.1. Company Overview
12.3.6.2. Financial Performance
12.3.6.3. Product Pipeline Benchmarking
12.3.6.4. Strategic Initiatives
12.3.7. Labcorp Drug Development
12.3.7.1. Company Overview
12.3.7.2. Financial Performance
12.3.7.3. Product Pipeline Benchmarking
12.3.7.4. Strategic Initiatives
12.3.8. Pfizer
12.3.8.1. Company Overview
12.3.8.2. Financial Performance
12.3.8.3. Product Pipeline Benchmarking
12.3.8.4. Strategic Initiatives
12.3.9. AstraZeneca
12.3.9.1. Company Overview
12.3.9.2. Financial Performance
12.3.9.3. Product Pipeline Benchmarking
12.3.9.4. Strategic Initiatives
12.3.10. Biogen
12.3.10.1. Company Overview
12.3.10.2. Financial Performance
12.3.10.3. Product Pipeline Benchmarking
12.3.10.4. Strategic Initiatives
12.3.11. Eli Lilly
12.3.11.1. Company Overview
12.3.11.2. Financial Performance
12.3.11.3. Product Pipeline Benchmarking
12.3.11.4. Strategic Initiatives
12.3.12. Alzheon
12.3.12.1. Company Overview
12.3.12.2. Financial Performance
12.3.12.3. Product Pipeline Benchmarking
12.3.12.4. Strategic Initiatives
12.3.13. GAP Network
12.3.13.1. Company Overview
12.3.13.2. Financial Performance
12.3.13.3. Product Pipeline Benchmarking
12.3.13.4. Strategic Initiatives
12.3.14. BDD Pharma
12.3.14.1. Company Overview
12.3.14.2. Financial Performance
12.3.14.3. Product Pipeline Benchmarking
12.3.14.4. Strategic Initiatives
12.3.15. Re:Cognition Health
12.3.15.1. Company Overview
12.3.15.2. Financial Performance
12.3.15.3. Product Pipeline Benchmarking
12.3.15.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Neurology Clinical Trials Market Estimates and Forecasts, Region, 2021 - 2033 (USD Million)
Table 4 Global Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 5 Global Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 6 Global Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 7 Global Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 8 Global Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 9 Global Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 10 Global Neurology Clinical Trials Market Estimates and Forecasts, Region, 2021 - 2033 (USD Million)
Table 11 North America Neurology Clinical Trials Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 12 North America Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 13 North America Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 14 North America Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 15 North America Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 16 North America Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 17 North America Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 18 U.S. Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 19 U.S. Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 20 U.S. Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 21 U.S. Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 22 U.S. Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 23 U.S. Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 24 Canada Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 25 Canada Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 26 Canada Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 27 Canada Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 28 Canada Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 29 Canada Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 30 Mexico Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 31 Mexico Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 32 Mexico Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 33 Mexico Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 34 Mexico Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 35 Mexico Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 36 Europe Neurology Clinical Trials Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 37 Europe Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 38 Europe Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 39 Europe Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 40 Europe Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 41 Europe Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 42 Europe Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 43 UK Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 44 UK Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 45 UK Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 46 UK Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 47 UK Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 48 UK Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 49 Germany Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 50 Germany Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 51 Germany Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 52 Germany Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 53 Germany Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 54 Germany Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 55 France Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 56 France Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 57 France Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 58 France Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 59 France Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 60 France Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 61 Italy Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 62 Italy Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 63 Italy Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 64 Italy Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 65 Italy Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 66 Italy Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 67 Spain Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 68 Spain Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 69 Spain Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 70 Spain Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 71 Spain Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 72 Spain Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 73 Denmark Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 74 Denmark Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 75 Denmark Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 76 Denmark Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 77 Denmark Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 78 Denmark Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 79 Sweden Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 80 Sweden Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 81 Sweden Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 82 Sweden Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 83 Sweden Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 84 Sweden Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 85 Norway Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 86 Norway Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 87 Norway Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 88 Norway Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 89 Norway Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 90 Norway Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 91 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 92 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 93 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 94 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 95 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 96 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 97 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 98 Japan Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 99 Japan Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 100 Japan Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 101 Japan Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 102 Japan Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 103 Japan Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 104 China Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 105 China Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 106 China Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 107 China Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 108 China Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 109 China Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 110 India Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 111 India Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 112 India Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 113 India Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 114 India Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 115 India Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 116 Thailand Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 117 Thailand Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 118 Thailand Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 119 Thailand Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 120 Thailand Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 121 Thailand Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 122 South Korea Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 123 South Korea Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 124 South Korea Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 125 South Korea Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 126 South Korea Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 127 South Korea Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 128 Australia Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 129 Australia Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 130 Australia Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 131 Australia Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 132 Australia Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 133 Australia Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 134 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 135 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 136 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 137 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 138 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 139 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 140 Latin America Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 141 Brazil Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 142 Brazil Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 143 Brazil Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 144 Brazil Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 145 Brazil Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 146 Brazil Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 147 Argentina Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 148 Argentina Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 149 Argentina Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 150 Argentina Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 151 Argentina Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 152 Argentina Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 153 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
Table 154 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 155 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 156 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 157 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 158 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 159 Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 160 South Africa Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 161 South Africa Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 162 South Africa Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 163 South Africa Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 164 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 165 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 166 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 167 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 168 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 169 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 170 UAE Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 171 UAE Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 172 UAE Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 173 UAE Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 174 UAE Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 175 UAE Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 176 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 177 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 178 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 179 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 180 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 181 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 182 Oman Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 183 Oman Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 184 Oman Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 185 Oman Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 186 Oman Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 187 Oman Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
Table 188 Qatar Neurology Clinical Trials Market Estimates and Forecasts, Phase, 2021 - 2033 (USD Million)
Table 189 Qatar Neurology Clinical Trials Market Estimates and Forecasts, Study Design, 2021 - 2033 (USD Million)
Table 190 Qatar Neurology Clinical Trials Market Estimates and Forecasts, Indication, 2021 - 2033 (USD Million)
Table 191 Qatar Neurology Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021 - 2033 (USD Million)
Table 192 Qatar Neurology Clinical Trials Market Estimates and Forecasts, Indication by Phase, 2021 - 2033 (USD Million)
Table 193 Qatar Neurology Clinical Trials Market Estimates and Forecasts, Value Chain, 2021 - 2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Market Formulation & Validation
Figure 6 Commodity Flow Analysis
Figure 7 Value-Chain-Based Sizing & Forecasting
Figure 8 QFD Model Sizing & Forecasting
Figure 9 Bottom-up Approach
Figure 10 Market Snapshot
Figure 11 Segment Snapshot 1
Figure 12 Segment Snapshot 2
Figure 13 Competitive Landscape Snapshot
Figure 14 Parent market outlook, 2025 (USD Billion)
Figure 15 Ancillary market outlook, 2025 (USD Billion)
Figure 16 Neurology Clinical Trials Market Dynamics
Figure 17 Porter’s Five Forces Analysis
Figure 18 PESTEL Analysis
Figure 19 Neurology Clinical Trials Market: Phase outlook and key takeaways
Figure 20 Neurology Clinical Trials Market: Phase movement analysis
Figure 21 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 22 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 23 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 24 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 25 Neurology Clinical Trials Market: Study Design outlook and key takeaways
Figure 26 Neurology Clinical Trials Market: Study Design movement analysis
Figure 27 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 28 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 29 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 30 Neurology Clinical Trials Market: Indication outlook and key takeaways
Figure 31 Neurology Clinical Trials Market: Indication movement analysis
Figure 32 Alzheimer’s Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 33 Depression (MDD) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 34 Parkinson's Disease (PD) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 35 Epilepsy Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 36 Stroke Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 37 Traumatic Brain Injury (TBI) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 38 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 39 Huntington's Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 40 Muscle Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 41 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 42 Neurology Clinical Trials Market: Indication by Study Design outlook and key takeaways
Figure 43 Neurology Clinical Trials Market: Indication by Study Design movement analysis
Figure 44 Alzheimer’s Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 45 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 46 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 47 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 48 Depression (MDD) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 49 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 50 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 51 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 52 Parkinson's Disease (PD) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 53 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 54 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 55 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 56 Epilepsy Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 57 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 58 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 59 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 60 Stroke Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 61 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 62 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 63 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 64 Traumatic Brain Injury (TBI) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 65 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 66 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 67 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 68 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 69 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 70 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 71 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 72 Huntington's Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 73 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 74 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 75 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 76 Muscle Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 77 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 78 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 79 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 80 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 81 Interventional Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 82 Observational Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 83 Expanded Access Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 84 Neurology Clinical Trials Market: Indication by Phase outlook and key takeaways
Figure 85 Neurology Clinical Trials Market: Indication by Phase movement analysis
Figure 86 Alzheimer’s Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 87 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 88 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 89 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 90 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 91 Depression (MDD) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 92 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 93 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 94 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 95 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 96 Parkinson's Disease (PD) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 97 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 98 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 99 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 100 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 101 Epilepsy Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 102 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 103 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 104 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 105 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 106 Stroke Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 107 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 108 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 109 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 110 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 111 Traumatic Brain Injury (TBI) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 112 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 113 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 114 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 115 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 116 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 117 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 118 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 119 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 120 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 121 Huntington's Disease Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 122 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 123 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 124 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 125 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 126 Muscle Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 127 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 128 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 129 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 130 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 131 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 132 Phase I Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 133 Phase II Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 134 Phase III Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 135 Phase IV Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 136 Neurology Clinical Trials Market: Value Chain outlook and key takeaways
Figure 137 Neurology Clinical Trials Market: Value Chain movement analysis
Figure 138 In-house Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 139 Outsourcing Market Estimates and Forecast, 2021 - 2033 (USD Million)
Figure 140 Regional Marketplace: Key Takeaways
Figure 141 North America Neurology Clinical Trials Market estimates and forecasts, 2021-2033 (USD Million)
Figure 142 Key country dynamics
Figure 143 U.S. Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 144 Key country dynamics
Figure 145 Canada Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 146 Key country dynamics
Figure 147 Mexico Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 148 Europe Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 149 Key country dynamics
Figure 150 UK Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 151 Key country dynamics
Figure 152 Germany Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 153 Key country dynamics
Figure 154 France Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 155 Key country dynamics
Figure 156 Italy Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 157 Key country dynamics
Figure 158 Spain Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 159 Key country dynamics
Figure 160 Denmark Neurology Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 161 Key country dynamics
Figure 162 Sweden Neurology Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 163 Key country dynamics
Figure 164 Norway Neurology Clinical Trials market estimates and forecasts, 2021 - 2033 (USD Million)
Figure 165 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 166 Key country dynamics
Figure 167 Japan Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 168 Key country dynamics
Figure 169 China Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 170 Key country dynamics
Figure 171 India Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 172 Key country dynamics
Figure 173 Thailand Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 174 Key country dynamics
Figure 175 South Korea Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 176 Key country dynamics
Figure 177 Australia Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 178 Latin America Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 179 Key country dynamics
Figure 180 Brazil Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 181 Key country dynamics
Figure 182 Argentina Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 183 MEA Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 184 Key country dynamics
Figure 185 South Africa Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 186 Figure Key country dynamics
Figure 187 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 188 Key country dynamics
Figure 189 UAE Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 190 Key country dynamics
Figure 191 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 192 Key country dynamics
Figure 193 Oman Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Figure 194 Key country dynamics
Figure 195 Qatar Neurology Clinical Trials Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Companies Mentioned

  • Syneos Health
  • Icon Plc
  • Lindus Health
  • AbbVie
  • GlaxoSmithKline
  • Aurora Healthcare
  • Labcorp Drug Development
  • Pfizer
  • AstraZeneca
  • Biogen
  • Eli Lilly
  • Alzheon
  • GAP Network
  • BDD Pharma
  • Re:Cognition Health